Business | Thomson Reuters | Tuesday September 22, 2015
Drug maker Glenmark Pharmaceuticals is counting on strong growth in the United States, where it will launch a dozen new medicines, to offset weakness in emerging markets this year, its chief executive said.
www.ndtv.com/business